The global Anti-Snoring Devices and Snoring Surgery market was valued at USD 1,106.1 Million in 2020 and is expected to reach USD 2,522.9 Million by year 2028, at a CAGR of 11.1%.
According to Centers for Disease Control and Prevention (CDC), 1 in 3 American children born in 2000 will develop diabetes, and children under 10 years of age are already developing type II diabetes, primarily seen in adults—usually not until past the age of 40. Snoring is voluble inhalation or exhalation of air during sleep. It is a familiar dilemma among the current population and it distresses approximately 90 million American adults — 37 million on a regular basis. Snoring may happen nightly or erratically. Usually the male population and those who are obese are very risk prone to this problem, but snoring is a problem of both genders. Age and obesity are the main factors causing people to snore. It leads to disrupted sleep which leads to tiredness and drowsiness for the whole day. The two most general unpleasant health effects which are related to snoring are drowsiness and heart disease. About one-half of people who snore loudly have obstructive sleep apnea (OSA).
Top Companies Profiled in the Report Include:
Apnea Sciences Corporation, Airway Management Inc., Glaxosmithkline, PLC, Meditas Ltd, Sleeping Well LLC, Somnomed Limited, The Pure Sleep Company, Theravent, Inc. and Tomed Dr. Toussaint Gmbh.
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Anti-Snoring Devices And Snoring Surgery market in these key regions.
Country-wise regional analysis covers:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Spain
- Switzerland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Additionally, the report consists a detailed analysis of the segmentation of the Anti-Snoring Devices And Snoring Surgery market based on product types and end-use/application offered in the Anti-Snoring Devices And Snoring Surgery market.
Device Type (Revenue, USD Million; 2020–2028)
- Oral Application
- Mandibular Advancement Device
- Tongue Stabilizing Devices,
- Nasal Devices
- External Nasal Dilators (Nasal Strips)
- Other Nasal Devices (Nasal Stents, Nasal Clips, and Septal Stimulators)
- Positive Airway Pressure Devices
- Position Control Devices
- Chin Straps
- Tongue-Stabilizing Devices (TSDs)
- EPAP Therapy Devices
Surgical Procedure (Revenue, USD Million; 2020–2028)
- Uvulopalatopharyngoplasty Surgery
- Tonsillectomy and Adenoidectomy Surgery
- Maxillo-mandibular and Genioglossus Advancement Surgery
- Radiofrequency Ablation Surgery
- Pillar Procedure with Palatal Implants Surgery
- Laser-Assisted Uvulopalatoplasty
- Injection Snoreplasty/Sclerotherapy
- Other Anti-Snoring Surgical Procedures
Distribution Channel (Revenue, USD Million; 2020–2028)
- Retail
- Direct Sales
End User (Revenue, USD Million; 2020–2028)
- Hospitals
- Community Healthcare
- Sleep Clinics
- Home Healthcare
- Ambulatory Surgical entres
- Others
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
